| 发明名称 |
VACCINE COMPRISING A TLR-5 AGONIST AS ADJUVANT FOR USE IN CUTANEOUS IMMUNISATION |
| 摘要 |
The present invention provides immunogenic compositions comprising one or more antigens and an adjuvant for use in cutaneous immunisation wherein said adjuvant is a TLR-5 agonist. |
| 申请公布号 |
US2014322271(A1) |
申请公布日期 |
2014.10.30 |
| 申请号 |
US201214359401 |
申请日期 |
2012.11.19 |
| 申请人 |
GlaxoSmithKline Biologicals S.A. |
发明人 |
Garcon-Johnson Nathalie Marie-Josephe;Van Mechelen Marcelle Paulette;Plante Martin |
| 分类号 |
A61K39/29;A61K39/39;A61K9/00 |
主分类号 |
A61K39/29 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A patch comprising an immunogenic composition comprising one or more antigens and an adjuvant for use in cutaneous immunisation wherein said adjuvant is a TLR-5 agonist, wherein said patch comprises microprojections adapted to deliver immunogenic composition of the invention to the epidermis, and wherein at least part of the microprojections is biodegradable. |
| 地址 |
Rixensart BE |
